Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF
Status:
Terminated
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
To determine if Ozurdex implant can offer an effective treatment for macular edema associated
with retinal vein occlusion when treatment with intravitreal Avastin, Lucentis, or Eylea have
not demonstrated a significant response.
Phase:
N/A
Details
Lead Sponsor:
Retina Research Institute, LLC
Collaborators:
Retina-Vitreous Associates Medical Group West Coast Retina Medical Group, Inc.